Cardinal Health recently introduced its Flexal Nitrile exam glove that offers the flexibility and barrier protection of a nitrile glove with the tactile sensitivity of a latex one.
Developed in response to customer requests for a strong, comfortable, synthetic glove with the tactility of latex, the Flexal exam glove features a textured-fingertip that provides enhanced sensitivity over traditional nitrile gloves without compromising reliability or durability. As the newest nitrile glove in the Cardinal Health portfolio, Flexal provides a high-quality and cost-effective alternative to latex and nitrile gloves currently available in the market.
"Cardinal Health developed the Flexal Nitrile exam glove to improve a clinicians sense of touch while maintaining confidenc e in its barrier protection," says Lisa Ashby, president of category management for the medical segment of Cardinal Health. "We continue to innovate our product portfolio to provide cost-effective solutions that will help our customers improve the quality of care, and were pleased to offer this alternative in Flexal."
A powder-free addition to Cardinal Healths exam glove portfolio, Flexal complements the Esteem®, Flexam®, InstaGard®, and Triflex® product lines and the Esteem, Duraprene, Protegrity® and Triflex families of Cardinal Health surgical gloves.
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.